Will big shareholder(EPF, KWAP ...) sell tomorrow: No, market cannot asorb it. One share they sell, they lose more and more.
Ikan bilis: some sell, some hold, and many wait at the bottom.
Serba has replied quite strongly, but the matter will need time to clear itself, regardless of the result.
Let say Serba will drop to 1. Remember last month, boss easily brought it from 1.6 to 1.9 .If any of the big shareholder want to do it,
they will just bring it up easily when investor cool their heads.
Short seller, if use too much margin and too greedy. And a sudden good news come out or an insider development,
and big shareholder start to act, then there will be consequence. If big sharks just let it be, then short seller will make some money.
Ikan bilis will treat you well.

just some though, don't throw stones ya.

a lot of angel and nobble investor in KNM suddenly. PE is now 9, O&G activities is resuming.

good earning prospect, O&G theme. KNM is attracting more voices with different purposes.

can we mute all of the noise above! simple truth, PE =9, earning keep rising quater after quater, O&G activities are going to resume everywhere, more job all related companies.

Not sure how dpharma and pharma is going to involve in vaccines, but surely this is not the job of some companies just singing a MOU, rent a truck or grab car and deliver it. Read a bit more about vaccines, fill and finish. Fill-finish process is important to achieving necessary coverage
• Fill-finish is process of filling vials and syringes and packaging them in highly sterile conditions
• Fill-finish is a major hurdle on the path to vaccine distribution . https://www.aon.com/getmedia/6910fe60-3e2d-44d2-b081-4a718711605e/COVID-19-Vaccine-Development.aspx

https://focusmalaysia.my/mainstream/immigration-system-to-be-awarded-in-aug-here-are-6-frontrunners/

will Pharma benefit from this ? https://www.theedgemarkets.com/article/sabah-buys-nearly-15-million-face-masks-people

Scicom earning per share is quite the same as myeg, dsonic. And PE is lower. This one is a bargain. It won't be affected by politics which is also a good thing. Doing fine in covid time also. Not sure if Scicom will stand a chance for government projects, but this is already good.

"secure 25 mil" profit before tax.it is going to be a big year for dpharma. more to come https://www.theedgemarkets.com/article/duopharma-cashes-newly-listed-korean-investee-firm-secures-rm25-mil

25% increase YoY. stable result through out. strong sailing through Covid. The result has not taken in their recent businesses (i.e with Shoppee and Collaboration with Qualitas in Covid testing platform ...). just nice.

so many selling ...maybe using margin and have to sell. Hextar will be doing good this time with its sales, so price will go up after those seller is gone.

Reasonable result. Other than the "unrealized loss due to weak RM/USD", it is benefiting from "higher healthcare budget for 2020" and "extending contract until Dec 31, 2021". Dpharma will sail well through this Covid uncertainty even if more to come.

revenue is 51.9 mil, earning before tax is 4.6 mil. But what is this one-off non-cash 11 mil depreciation ? They don't really lose any cash on this item.... Management want to utilize this time to not paying Tax is it? It is also weird that no Insider/Director selling if the result is in deed a loss? Any idea from anyone?

why last quater result is bad while naphtha price is low. anyone can explain a bit for me?

Goh said Karex had seen growing demand as people worldwide are confined to their homes, while Indian media reported that condom sales had jumped 25-35 percent in the week after the country of 1.3 billion people announced a lockdown. https://www.dailymail.co.uk/news/article-8199273/UN-warns-devastating-condom-shortage-coronavirus-forces-major-producers-close-factories.html

in the midterm this one will be doing fine. People will move/travel less for quite sometime, lock down or not lock down doesn't matter. And the product is sold in Pharmacies (and others), which is allowed to operate all the time.

good job, sell. btw, for those who read from the research above: Pharma is the one who works more with Hospital. This is a good counter too :)

turn out AA has a good digital platform ready and Teleport as a logistic arm.Active move and strong preparation then https://www.theedgemarkets.com/article/airasia-launches-sos-campaign-help-merchants-amid-covid19-crisis

"AirAsia employs 29,000 people" government will want to help out a bit if needed, or at least showing support since AA has enough cash to sail until end of the year. If AA fails, other opponent will fill the space and Malaysia economy will become weaker. Many reasons for AA to survive, but yeah, it gonna be tough. sell sell sell, someone are waiting at the bottom.